Everything below concerns SR9009. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Moreover, various protocols and methods of analyzing IDPs, such as studies based on quantitative analysis of GC content in genes and their respective chromosomal bands, have been used to understand functional IDP segments.
=== Integration of Biocon Biologics === On 6 December 2025, Biocon announced that it would fully integrate its biosimilars subsidiary Biocon Biologics Limited (BBL) as a wholly owned subsidiary, in a corporate action that valued BBL at US$5.5 billion and marked a pivot away from a previously planned initial public offering (IPO) of the biosimilars business. The company said the integration would simplify the group's corporate structure, remove the holding-company discount that had weighed on its valuation, and combine its generics and biosimilars operations into a single listed entity focused on diabetes, oncology and immunology. Under the plan, Biocon acquired the minority stakes held by Serum Institute Life Sciences, Tata Capital Growth Fund II and Activ Pine LLP through a share swap of 70.28 Biocon shares for every 100 BBL shares, priced at ₹405.78 per Biocon share. It also bought out the residual stake held by Mylan Inc. (Viatris) for US$815 million, comprising US$400 million in cash and US$415 million via a share swap, with the swap ratios based on independent valuations by EY. To fund the cash component payable to Viatris, Biocon raised approximately ₹4,150 crore (about US$460 million) through a qualified institutional placement (QIP) completed on 14 January 2026. The integration was completed by 31 March 2026, making Biocon Biologics a wholly owned subsidiary of Biocon Limited and creating a unified entity spanning biosimilars, insulins, generics and peptides. The leadership transition that followed is described under Corporate governance.
=== Cell signaling and cell communication === Neither sponges nor the placozoan Trichoplax adhaerens appear to be equipped with neuron synapses, however they both possess several factors related to the same synaptic function. Therefore, it is likely that central features involved in synaptic transmission arose early in metazoan evolution, most likely around the time that much of the life on Earth was transitioning to multicellularity. It was found that the Munc18/syntaxin 1 complex could be an important component for the production of the SNARE protein. The secretion of SNARE protein from synaptic vesicles is believed to be critical for neuronal communication. The Munc18/syntaxin 1 complex found in M. brevicollis is both structurally and functionally similar to the metazoan complex. This suggests that it constitutes an important step in the reaction pathway toward SNARE assembly. It is believed that the common ancestor of choanoflagellates and metazoans used this primordial secretion machinery as a precursor to synaptic communication. This mechanism would eventually be used for cell-cell communication in animals.
Internal divisions remained between the bipartisan political forces, occasionally igniting very bloody civil wars, the most significant being the Thousand Days' War (1899–1902), in which between 100 and 180 thousand Colombians lost their lives when the Liberal Party, supported by Venezuela, Ecuador, Nicaragua, and Guatemala rebelled against the Nationalist government and took control of Santander, ultimately being defeated in 1902 by nationalist forces.
DHA (dihydroxyacetone, also known as glycerone) is not a dye, stain or paint, but causes a chemical reaction with the amino acids in the dead layer on the skin surface. One of the pathways is a free radical-mediated Maillard reaction. The other pathway is the conventional Maillard reaction, a process well known to food chemists that causes the browning that occurs during food manufacturing and storage. It does not involve the underlying skin pigmentation nor does it require exposure to ultraviolet light to initiate the color change. However, for the 24 hours after self-tanner is applied, the skin is especially susceptible to ultraviolet, according to a 2007 study led by Katinka Jung of the Gematria Test Lab in Berlin. Forty minutes after the researchers treated skin samples with high levels of DHA they found that more than 180 percent additional free radicals formed during sun exposure compared with untreated skin. Another self-tanner ingredient, erythrulose, produced a similar response at high levels. For a day after self-tanner application, excessive sun exposure should be avoided and sunscreen should be worn outdoors, they say; an antioxidant cream could also minimize free radical production. Although some self-tanners contain sunscreen, its effect will not last long after application, and a fake tan itself will not protect the skin from UV exposure. The study by Jung et al. further confirms earlier results demonstrating that dihydroxyacetone in combination with dimethylisosorbide enhances the process of (sun-based) tanning.
Sources: en.wikipedia.org
Robert Fripp – guitar, keyboards, Mellotron, electronics (1968–1974, 1981–1984, 1994–2008, 2013–2021) Mel Collins – saxophones, flute, bass flute, clarinet, bass clarinet, Mellotron, backing vocals (1970–1972, 2013–2021) Tony Levin – bass guitar, Chapman Stick, upright bass, synthesisers, backing vocals (1981–1984, 1994–1999, 2003–2008, 2013–2021) Pat Mastelotto – drums, percussion, programming (1994–2008, 2013–2021) Gavin Harrison – drums, percussion (2007–2008, 2013–2021) Jakko Jakszyk – lead vocals, guitar, flute, keyboards (2013–2021) Jeremy Stacey – drums, keyboards, backing vocals (2016–2021)
April 21, 1944: Women are granted the right to vote and to stand for election, by ordinance of the Provisional Government of the French Republic then located in Algiers. April 12, 1945: Ordinance on divorce and legal separation. April 29, 1945: First vote with women participating as voters, during municipal elections. September 1, 1945: Ordinance on paternal correction, notably abolishing the "right to paternal correction." October 4, 1945: Ordinance establishing Social Security; its provisions include the creation of mandatory maternity leave (14 weeks) with compensation amounting to half of the salary. October 9, 1945: Creation of the National School of Administration (ENA), which accepts women, provided they do not seek positions strictly reserved for men. October 19, 1945: Ordinance establishing the French Nationality Code. November 2, 1945: Ordinance on maternal and child protection. April 11, 1946: Law allowing women to access the judiciary. April 13, 1946: Ban on brothels and strengthening the fight against pimping, by the so-called "Marthe Richard law." April 24, 1946: Law establishing a sanitary and social registry of prostitution. May 18, 1946: Law granting an additional leave to heads of household, whether salaried, civil servants, or public service agents, for each birth in their household. July 30, 1946: Order repealing provisions allowing wage reductions for "female wages." August 22, 1946: Law establishing the family benefits system.
He struggles to adapt to civilian life for which he sought counseling. He is the primary parent to his pre-adolescent daughter, Mary, while his wife, Geena Williams Conner, is still serving in the military abroad. D.J. lands a job with a vending machine company, improving his financial situation, but after receiving a promotion, he works long hours, often away from Lanford. He agrees to allow Mary to stay at the Conner house during the week so she will not be home alone.
== Career == After postdoctoral research at AMOLF (FOM Institute for Atomic and Molecular Physics, Amsterdam) and University of Minnesota, Hamley was appointed as lecturer in Physics at the University of Durham in 1993 where he worked until 1995. He moved to the Department of Chemistry at the University of Leeds in 1995 and was promoted to become Professor of Polymer Materials and Director of the Centre for Self-Organising Molecular Systems in 2004. He moved to the University of Reading as Diamond Professor of Physical Chemistry in 2005. This was a five-year, joint appointment with Diamond Light Source. His past research concerned the self-assembly of block copolymers. Most recently he has developed interests in peptide and peptide conjugate self-assembly, including molecules with bioactivity such as amyloid peptides peptide hormones, antimicrobial peptides, peptides in cosmetic applications and peptides with anti-cancer activity. Several of these show promise as therapeutics.
Inhalation of tobacco smoke causes several immediate responses within the heart and blood vessels. Within one minute, the heart rate begins to rise, increasing by as much as 30 percent during the first 10 minutes of smoking. Carbon monoxide in tobacco smoke exerts negative effects by reducing the blood's oxygen-carrying ability. Smoking also increases the chance of heart disease, stroke, atherosclerosis, and peripheral artery disease. Several ingredients of tobacco lead to the narrowing of blood vessels, increasing the likelihood of a blockage, and thus a heart attack or stroke. According to a study by an international team of researchers, people under 40 are five times more likely to have a heart attack if they are smokers. Exposure to tobacco smoke is known to increase oxidative stress in the body by various mechanisms, including depletion of plasma antioxidants such as vitamin C. Research by American biologists has shown that cigarette smoke also influences the process of cell division in the cardiac muscle and changes the heart's shape. Smoking tobacco has also been linked to Buerger's disease (thromboangiitis obliterans), the acute inflammation and thrombosis (clotting) of arteries and veins of the hands and feet. Although cigarette smoking causes a greater increase in the risk of cancer than cigar smoking, people who smoke cigars still have an increased risk for many health problems, including cancer, when compared to people who do not smoke.
Sources: en.wikipedia.org
=== 6 April === Fu Cong, China's Ambassador to the European Union, explained in interviews that the recently declared "friendship with no limits" between Russia and China is actually "nothing but rhetoric" and that China will continue to not recognize Crimea as a part of Russia. In another interview, he denied China having any plans to provide Russia with weapons. This was something that U.S. officials have accused China of preparing. He is also reported to have stated that what is most urgent for China is "to stop the fighting to save lives". Ukroboronprom announced that it would launch joint manufacture of 125mm tank rounds for Soviet era tanks with Polska Grupa Zbrojeniowa. Ukroboronprom stated that Poland will be the second NATO country to help Ukraine manufacture Soviet-era shells. Classified documents of US–NATO counter-offensive plan details were leaked from the Pentagon via social media sites. According to experts, the plans have been edited prior to publication to decrease estimates of Russian losses and increase estimates of Ukrainian losses. Some of the experts have questioned the authenticity of the documents and suggested that the leak could be part of a Russian disinformation campaign.
Heparin acts as an anticoagulant, preventing the formation of clots and extension of existing clots within the blood. Heparin itself does not break down clots that have already formed, instead, it prevents clot formation by inhibiting thrombin and other procoagulant serine proteases. Heparin is generally used for anticoagulation for the following conditions:
== Delivery == In 2015, Jain et al. described a trans-acting DNA-based amphiphatic delivery system for convenient delivery of poly A tailed uncharged nucleic acids (UNA) such as PNAs and morpholinos, so that several UNA's can be easily screened ex vivo.
== Veterinary use == Naloxone is used to reverse pure μ-opioid receptor agonists and for opioid reversal during cardiopulmonary arrest in cats and dogs. This is often given intravenously but instranasal administration works in the dog at higher doses. Renarcotisation can occur with naloxone administration, especially with morphinans. Naloxone administration has been reported to result in altered mental status and blepharospasm. Aetiology of this is unknown but could be due to either withdrawal, systemic hypertension, or rapid changes to the cerebral vascular tone. One study in horses reported that naloxone administration reduced increases in right ventricular pressure and heart rate caused by endotoxic shock.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.